Increased Proportions of Bifidobacterium and the Lactobacillus Group and Loss of Butyrate-Producing Bacteria in Inflammatory Bowel Disease
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Dysbiosis in the intestinal microbiota of persons with inflammatory bowel disease (IBD) has been described, but there are still varied reports on changes in the abundance of Bifidobacterium and Lactobacillus organisms in patients with IBD. The aim of this investigation was to compare the compositions of mucosa-associated and fecal bacteria in patients with IBD and in healthy controls (HCs). Fecal and biopsy samples from 21 HCs, 21 and 15 Crohn's disease (CD) patients, and 34 and 29 ulcerative colitis (UC) patients, respectively, were analyzed by quantitative real-time PCR targeting the 16S rRNA gene. The bacterial numbers were transformed into relative percentages for statistical analysis. The proportions of bacteria were uniformly distributed along the colon regardless of the disease state. Bifidobacterium was significantly increased in the biopsy specimens of active UC patients compared to those in the HCs (4.6% versus 2.1%, P = 0.001), and the proportion of Bifidobacterium was significantly higher in the biopsy specimens than in the fecal samples in active CD patients (2.7% versus 2.0%, P = 0.012). The Lactobacillus group was significantly increased in the biopsy specimens of active CD patients compared to those in the HCs (3.4% versus 2.3%, P = 0.036). Compared to the HCs, Faecalibacterium prausnitzii was sharply decreased in both the fecal and biopsy specimens of the active CD patients (0.3% versus 14.0%, P < 0.0001 for fecal samples; 0.8% versus 11.4%, P < 0.0001 for biopsy specimens) and the active UC patients (4.3% versus 14.0%, P = 0.001 for fecal samples; 2.8% versus 11.4%, P < 0.0001 for biopsy specimens). In conclusion, Bifidobacterium and the Lactobacillus group were increased in active IBD patients and should be used more cautiously as probiotics during the active phase of IBD. Butyrate-producing bacteria might be important to gut homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with inflammatory bowel disease (IBD) have been associated with reduced bacterial diversity and a decline in butyrate-producing bacteria such as Faecalibacterium prausnitzii, indicating the importance of gut dysbiosis in IBD [138, 139].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [139]
In the citing paper
“mucosa-associated microbes preferentially regulate host homeostasis, as is evident in the induction of T-cell immune responses, as well as maintaining serotonin biosynthesis from dietary tryptophan in the mucosa.28, 29, 30, 31, 32, 33”
From Distinct Microbiome-Neuroimmune Signatures Correlate With Functional Abdominal Pain in Children With Autism Spectrum Disorder (2017) · cites this paper as [28]
Citations
Cites
The gut microbiota shapes intestinal immune responses during health and disease
Round, J. L., & Mazmanian, S. K. (2009) · Nature Reviews Immunology · doi:10.1038/nri2515 · Cited by 5,029 · cited 1×
“In our study, we found that the proportions of detected mucosa-associated bacteria in healthy gastrointestinal tracts were uniformly distributed along the colon, which was in accordance with the findings from a previous study (23, 24).”
ResultFrank, D. N., St. Amand, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., & Pace, N. R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706625104 · Cited by 4,611 · cited 2×
“leptum group was strikingly low in mucosa-associated microbiotas (40, 41).”
BackgroundSokol, H., Pigneur, B., Watterlot, L., Lakhdari, O., Bermúdez-Humarán, L. G., Gratadoux, J.-J., Blugeon, S., Bridonneau, C., Furet, J.-P., Corthier, G., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804812105 · Cited by 4,413 · cited 1×
“One study suggested that Faecalibacterium prausnitzii prevents 2,4,6-trinitrobenzenesulfonic acid (TNBS)induced colitis (16).”
BackgroundDevelopment of a Crohn's Disease Activity Index
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80163-1 · Cited by 3,152
Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.
Best, W. R., Becktel, J. M., Singleton, J. W., & Kern, F. (1976) · PubMed · Cited by 3,147
Microbial Influences in Inflammatory Bowel Diseases
Sartor, R. B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.059 · Cited by 1,927
Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis
Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,757
Microbes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Mucosal flora in inflammatory bowel disease
Swidsinski, A., Ladhoff, A., Pernthaler, A., Swidsinski, S., Loening–Baucke, V., Ortner, M., Weber, J., Hoffmann, U., Schreiber, S., Dietel, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.30294 · Cited by 1,346
Kruis, W., Frič, P., Pokrotnieks, J., Lukáš, M., Fixa, B., Kaščák, M., Kamm, M. A., Weismueller, J., Beglinger, C., Stolte, M., et al. (2004) · Gut · doi:10.1136/gut.2003.037747 · Cited by 1,285
Cited by
Parada Venegas, D., De la Fuente, M. K., Landskron, G., González, M. J., Quera, R., Dijkstra, G., Harmsen, H. J. M., Faber, K. N., & Hermoso, M. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00277 · Cited by 3,820
Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism
Morrison, D. J., & Preston, T. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1134082 · Cited by 3,781
“prausnitzii.(21,22) A similar loss of diversity has been observed in other auto-immune pathologies, such as psioaritic arthritis, suggesting a role for the microbiota and its metabolites in immune regulation.”
BackgroundAlterations of the human gut microbiome in multiple sclerosis
Jangi, S., Gandhi, R., Cox, L. M., Li, N., von Glehn, F., Yan, R., Patel, B., Mazzola, M. A., Liu, S., Glanz, B. L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12015 · Cited by 1,307
The gut microbiota in anxiety and depression—A systematic review
Simpson, C. A., Diaz-Arteche, C., Eliby, D., Schwartz, O. S., Simmons, J. G., & Cowan, C. S. M. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2020.101943 · Cited by 912
The gut microbiota and inflammatory bowel disease
Matsuoka, K., & Kanai, T. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0454-4 · Cited by 804
“Among Firmicutes, a decrease in the Clostridium leptum groups, especially Faecalibacterium prausnitzii , has been reported in many studies [7, 13, 14].”
Khan, I., Ullah, N., Zha, L., Bai, Y., Khan, A., Zhao, T., Che, T., & Zhang, C. (2019) · Pathogens · doi:10.3390/pathogens8030126 · Cited by 771
Human gut microbiota in health and disease: Unveiling the relationship
Afzaal, M., Saeed, F., Shah, Y. A., Hussain, M., Rabail, R., Socol, C. T., Hassoun, A., Pateiro, M., Lorenzo, J. M., Rusu, A. V., et al. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.999001 · Cited by 762
“Phyla Firmicutes, Bacteroides, Actinobacteria, Proteobacteria, and Verrucomicrobia contribute to the significant resident bacterial populations in the gut microbiome (Fava et al., 2019).”
InfluentialMichielan, A., & D’Incà, R. (2015) · Mediators of Inflammation · doi:10.1155/2015/628157 · Cited by 709
“To date the ones with proven efficacy are Escherichia coli Nissle 1917, Bifidobacterium, Lactobacillus rhamnosus GG, or the multispecies VSL#3 which contains eight different probiotics [132].”
BackgroundBedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642
Pittayanon, R., Lau, J. T., Leontiadis, G. I., Tse, F., Yuan, Y., Surette, M., & Moayyedi, P. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.11.294 · Cited by 623
Gasaly, N., de Vos, P., & Hermoso, M. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.658354 · Cited by 578
Links of gut microbiota composition with alcohol dependence syndrome and alcoholic liver disease
Dubinkina, V. B., Tyakht, A. V., Odintsova, V. Y., Yarygin, K. S., Kovarsky, B. A., Pavlenko, A. V., Ischenko, D. S., Popenko, A. S., Alexeev, D. G., Taraskina, A. Y., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0359-2 · Cited by 465
“taxa, along with the Streptococcus and Lactobacillus, could be transient food-associated microbes, there is a growing body of evidence suggesting that levels of Bifidobacterium can increase in pathologies like alcoholic hepatitis [30] and inflammatory bowel diseases [31].”
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease
Weingarden, A. R., & Vaughn, B. P. (2017) · Gut Microbes · doi:10.1080/19490976.2017.1290757 · Cited by 463
Microbial network disturbances in relapsing refractory Crohn’s disease
Swiss IBD Cohort Investigators, Yilmaz, B., Juillerat, P., Øyås, O., Ramon, C., Bravo, F. D., Franc, Y., Fournier, N., Michetti, P., Mueller, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0308-z · Cited by 428
Probiotics, prebiotics and synbiotics: Safe options for next-generation therapeutics
Yadav, M. K., Kumari, I., Singh, B., Sharma, K. K., & Tiwari, S. K. (2022) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-021-11646-8 · Cited by 403
“Contrary to this , increase in Bifidobacterium and Lactobacillus population (Wang et al. 2014) and decrease in Clos t r id ium lep tum and Faecalibacterium prausnitzii(Prosberg et al. 2016) have been reported in active CD patients (Ahlawat et al. 2021).”
ResultGonçalves, P., Araújo, J. R., & Di Santo, J. P. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izx029 · Cited by 393
Thirty Years of Lactobacillus rhamnosus GG: A Review
Capurso, L. (2019) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001170 · Cited by 381
Zhou, X., Li, W., Wang, S., Zhang, P., Wang, Q., Xiao, J., Zhang, C., Zheng, X., Xu, X., Xue, S., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.03.028 · Cited by 378
Intestinal Lactobacillus in health and disease, a driver or just along for the ride?
Heeney, D. D., Gareau, M. G., & Marco, M. L. (2018) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2017.08.004 · Cited by 369
“Current Opinion in Biotechnology 2018, 49:140–147 [26,27] (Table 1).”
BackgroundEscherichia coli Pathobionts Associated with Inflammatory Bowel Disease
Mirsepasi-Lauridsen, H. C., Vallance, B. A., Krogfelt, K. A., & Petersen, A. M. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00060-18 · Cited by 359
The Intestinal Metabolome: An Intersection Between Microbiota and Host
Ursell, L. K., Haiser, H. J., Van Treuren, W., Garg, N., Reddivari, L., Vanamala, J., Dorrestein, P. C., Turnbaugh, P. J., & Knight, R. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.001 · Cited by 355
Gut microbiota in early pediatric multiple sclerosis: a case−control study
Tremlett, H., Fadrosh, D. W., Faruqi, A. A., Zhu, F., Hart, J., Roalstad, S., Graves, J., Lynch, S., Waubant, E., & the US Network of Pediatric MS Centers (2016) · European Journal of Neurology · doi:10.1111/ene.13026 · Cited by 347
“Combined, these data indicate that early dysregulation in MS involves an increase in proinflammatory and a decrease in anti-inflammatory gut microbiota milieu [17,18].”
BackgroundMetagenomics of Parkinson’s disease implicates the gut microbiome in multiple disease mechanisms
Wallen, Z. D., Demirkan, A., Twa, G., Cohen, G., Dean, M. N., Standaert, D. G., Sampson, T. R., & Payami, H. (2022) · Nature Communications · doi:10.1038/s41467-022-34667-x · Cited by 346
Towards microbial fermentation metabolites as markers for health benefits of prebiotics
Verbeke, K. A., Boobis, A. R., Chiodini, A., Edwards, C. A., Franck, A., Kleerebezem, M., Nauta, A., Raes, J., van Tol, E. A. F., & Tuohy, K. M. (2015) · Nutrition Research Reviews · doi:10.1017/s0954422415000037 · Cited by 343
Cao, Y., Shen, J., & Ran, Z. H. (2014) · Gastroenterology Research and Practice · doi:10.1155/2014/872725 · Cited by 302
“prausnitzii counts after denaturing gradient gel electrophoresis (DGGE) by real-time PCR (RTPCR) [8, 12, 14–18, 20].”
BackgroundMethodThe food-gut axis: lactic acid bacteria and their link to food, the gut microbiome and human health
De Filippis, F., Pasolli, E., & Ercolini, D. (2020) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuaa015 · Cited by 303
“On the other hand, enrichment of lactobacilli was verified in conditions of Crohn’s disease (Wang et al. 2014; Lewis et al. 2017) and rheumatoid arthritis (Zhang et al.”
BackgroundLuna, R. A., Oezguen, N., Balderas, M., Venkatachalam, A., Runge, J. K., Versalovic, J., Veenstra-VanderWeele, J., Anderson, G. M., Savidge, T., & Williams, K. C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.11.008 · Cited by 295
A metagenomic study of the gut microbiome in Behcet’s disease
Ye, Z., Zhang, N., Wu, C., Zhang, X., Wang, Q., Huang, X., Du, L., Cao, Q., Tang, J., Zhou, C., et al. (2018) · Microbiome · doi:10.1186/s40168-018-0520-6 · Cited by 272
Wang, Y., Dilidaxi, D., Wu, Y., Sailike, J., Sun, X., & Nabi, X.-H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109914 · Cited by 270
Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications
Huang, R., Wu, F., Zhou, Q., Wei, W., Yue, J., Xiao, B., & Luo, Z. (2022) · Microbiological Research · doi:10.1016/j.micres.2022.127019 · Cited by 250
Butyrate and the Fine-Tuning of Colonic Homeostasis: Implication for Inflammatory Bowel Diseases
Gasaly, N., Hermoso, M. A., & Gotteland, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063061 · Cited by 240
Suskind, D. L., Brittnacher, M. J., Wahbeh, G., Shaffer, M. L., Hayden, H. S., Qin, X., Singh, N., Damman, C. J., Hager, K. R., Nielson, H., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000307 · Cited by 243
“This divergence from healthy individual’s fecal microbiota is characterized by a decrease in commensal bacteria including members of Firmicutes and Bacteroides as well as a relative increase in proinflammatory bacteria such as Enterobacteriaceae.1,2 In addition, a decrease in butyrate-producing bacterium that is impor…”
ResultInfluentialDysbiosis of the Gut Microbiome in Lung Cancer
Zhuang, H., Cheng, L., Wang, Y., Zhang, Y.-K., Zhao, M.-F., Liang, G.-D., Zhang, M.-C., Li, Y.-G., Zhao, J.-B., Gao, Y.-N., et al. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00112 · Cited by 235
“Members of Bifidobacterium have a variety of probiotic functions, such as improving inflammatory bowel disease, ulcerative colitis, Crohn’s disease, and colonic pouchitis (van den Broek et al., 2008; Wang et al., 2014; Klemenak et al., 2015; Liang et al., 2018).”
BackgroundChen, L., Wang, W., Zhou, R., Ng, S. C., Li, J., Huang, M., Zhou, F., Wang, X., Shen, B., A. Kamm, M., et al. (2014) · Medicine · doi:10.1097/md.0000000000000051 · Cited by 224
Self-citationHeat stress mediates changes in fecal microbiome and functional pathways of laying hens
Zhu, L., Liao, R., Wu, N., Zhu, G., & Yang, C. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9465-8 · Cited by 221
Microbiota fermentation-NLRP3 axis shapes the impact of dietary fibres on intestinal inflammation
Singh, V., Yeoh, B. S., Walker, R. E., Xiao, X., Saha, P., Golonka, R. M., Cai, J., Bretin, A. C. A., Cheng, X., Liu, Q., et al. (2019) · Gut · doi:10.1136/gutjnl-2018-316250 · Cited by 214
The role of Lactobacillus in inflammatory bowel disease: from actualities to prospects
Li, C., Peng, K., Xiao, S., Long, Y., & Yu, Q. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01666-w · Cited by 207
“butyrate-producing bacteria such as Lachnospiraceae and Ruminococcaceae, which was observed reduced in colitis, indicating that they may have cooperation in treating colitis [11, 51].”
BackgroundProsberg, M., Bendtsen, F., Vind, I., Petersen, A. M., & Gluud, L. L. (2016) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2016.1216587 · Cited by 210
“were conducted in Japan,[30,36] China,[31,32] India [37] and Europe (Belgium,[45] Spain,[29] France,[35] Germany,[34] Denmark [33]).”
BackgroundMethodInfluentialStoll, M. L., Kumar, R., Morrow, C. D., Lefkowitz, E. J., Cui, X., Genin, A., Cron, R. Q., & Elson, C. O. (2014) · Arthritis Research & Therapy · doi:10.1186/s13075-014-0486-0 · Cited by 208
“There are mixed data with respect to this genus in the context of IBD, with prior studies both showing elevated [31] as well as decreased presence [46].”
BackgroundResultMetaPro-IQ: a universal metaproteomic approach to studying human and mouse gut microbiota
Zhang, X., Ning, Z., Mayne, J., Moore, J. I., Li, J., Butcher, J., Deeke, S. A., Chen, R., Chiang, C.-K., Wen, M., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0176-z · Cited by 202
“Butyrate-producing bacteria are reported to be decreased in HFD-fed animals and in some human diseases such as obesity and IBD [28, 36, 38, 39].”
BackgroundParticipation of Short-Chain Fatty Acids and Their Receptors in Gut Inflammation and Colon Cancer
Carretta, M. D., Quiroga, J., López, R., Hidalgo, M. A., & Burgos, R. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.662739 · Cited by 197
Microbial lactate utilisation and the stability of the gut microbiome
Louis, P., Duncan, S. H., Sheridan, P. O., Walker, A. W., & Flint, H. J. (2022) · Gut Microbiome · doi:10.1017/gmb.2022.3 · Cited by 193
Microbiome, Metabolome and Inflammatory Bowel Disease
Ahmed, I., Roy, B., Khan, S., Septer, S., & Umar, S. (2016) · Microorganisms · doi:10.3390/microorganisms4020020 · Cited by 193
“, Roseburia hominis and Faecalibacterium prausnitzii) in their intestine, resulting in lower levels of butyrate [140,141].”
BackgroundGut microbial dysbiosis in indian children with autism spectrum disorders
Pulikkan, J., Maji, A., Dhakan, D. B., Saxena, R., Mohan, B., Anto, M. M., Agarwal, N., Grace, T., & Sharma, V. K. (2018) · Microbial Ecology · doi:10.1007/s00248-018-1176-2 · Cited by 189
“It has been suggested that dysbiosis in gut microbiota leads to an imbalance in the SCFAs levels in the circulatory system, which may lead to an increased gut permeability detrimental to the ASD children [74].”
BackgroundThe Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials
Schepici, G., Silvestro, S., Bramanti, P., & Mazzon, E. (2019) · Cell Transplantation · doi:10.1177/0963689719873890 · Cited by 188
Schoultz, I., & Keita, Å. V. (2019) · Cells · doi:10.3390/cells8020193 · Cited by 185
Stanley, D., Wu, S.-B., Rodgers, N., Swick, R. A., & Moore, R. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104739 · Cited by 183
Beneficial Effect of Intestinal Fermentation of Natural Polysaccharides
Zhang, T., Yang, Y., Liang, Y., Jiao, X., & Zhao, C. (2018) · Nutrients · doi:10.3390/nu10081055 · Cited by 184
Soil exposure modifies the gut microbiota and supports immune tolerance in a mouse model
Ottman, N., Ruokolainen, L., Suomalainen, A., Sinkko, H., Karisola, P., Lehtimäki, J., Lehto, M., Hanski, I., Alenius, H., & Fyhrquist, N. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.06.024 · Cited by 177
Aldars-García, L., Chaparro, M., & Gisbert, J. P. (2021) · Microorganisms · doi:10.3390/microorganisms9050977 · Cited by 178
Ulcerative colitis: molecular insights and intervention therapy
Liang, Y., Li, Y., Lee, C., Yu, Z., Chen, C., & Liang, C. (2024) · Molecular Biomedicine · doi:10.1186/s43556-024-00207-w · Cited by 163
Adhesion Properties of Lactic Acid Bacteria on Intestinal Mucin
Nishiyama, K., Sugiyama, M., & Mukai, T. (2016) · Microorganisms · doi:10.3390/microorganisms4030034 · Cited by 170
“Interestingly, a previous study found increased proportions of Lactobacillus in patients with IBD [54].”
ResultThe Role of Dietary Nutrients in Inflammatory Bowel Disease
Sugihara, K., Morhardt, T. L., & Kamada, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03183 · Cited by 166
“The abundance of butyrate-producing bacteria, such as Roseburia hominis and Faecalibacterium prausnitzii, is decreased in IBD patients (11, 108, 109) and, therefore, fecal SCFAs levels are lower in IBD patients compared to controls (20).”
BackgroundGut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease
Guo, X., Huang, C., Xu, J., Xu, H., Liu, L., Zhao, H., Wang, J., Huang, W., Peng, W., Chen, Y., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2021.818902 · Cited by 165
“Several studies have suggested that a decrease in the abundance of butyrate-producing bacteria is one of the key hallmarks of gut dysbiosis seen in IBD (60, 115, 116).”
BackgroundDeterminants of IBD Heritability: Genes, Bugs, and More
Turpin, W., Goethel, A., Bedrani, L., & Croitoru, M. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy085 · Cited by 162
Metabolic Influences of Gut Microbiota Dysbiosis on Inflammatory Bowel Disease
Sultan, S., El-Mowafy, M., Elgaml, A., Ahmed, T. A. E., Hassan, H., & Mottawea, W. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.715506 · Cited by 156
Functional Impacts of the Intestinal Microbiome in the Pathogenesis of Inflammatory Bowel Disease
Li, J., Butcher, J., Mack, D., & Stintzi, A. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000215 · Cited by 151
“ical treatment or other therapeutic interventions are also potential confounders in studying the composition of the microbiota in IBD and should also be taken into account.(49) Considering the complexity of microbial compositions, an ecological analytical approach has been used to identify modules of interacting bacte…”
MethodClinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease
Suskind, D. L., Cohen, S. A., Brittnacher, M. J., Wahbeh, G., Lee, D., Shaffer, M. L., Braly, K., Hayden, H. S., Klein, J., Gold, B., et al. (2018) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000772 · Cited by 146
Van den Bossche, L., Hindryckx, P., Devisscher, L., Devriese, S., Van Welden, S., Holvoet, T., Vilchez-Vargas, R., Vital, M., Pieper, D. H., Vanden Bussche, J., et al. (2017) · Applied and Environmental Microbiology · doi:10.1128/aem.02766-16 · Cited by 146
“However, butyrateproducing bacteria are depleted in the fecal microbiota of IBD patients (49, 50, 56).”
Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 143
Mechanisms of Pediatric Inflammatory Bowel Disease
Peloquin, J. M., Goel, G., Villablanca, E. J., & Xavier, R. J. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032414-112151 · Cited by 150
Evaluation and comparison of short chain fatty acids composition in gut diseases
Niccolai, E., Baldi, S., Ricci, F., Russo, E., Nannini, G., Menicatti, M., Poli, G., Taddei, A., Bartolucci, G., Calabrò, A. S., et al. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i36.5543 · Cited by 139
Wang, R., Cao, S., Bashir, M. E. H., Hesser, L. A., Su, Y., Hong, S. M. C., Thompson, A., Culleen, E., Sabados, M., Dylla, N. P., et al. (2022) · Nature Biomedical Engineering · doi:10.1038/s41551-022-00972-5 · Cited by 154
Autism Spectrum Disorder as a Brain-Gut-Microbiome Axis Disorder
Saurman, V., Margolis, K. G., & Luna, R. A. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06133-5 · Cited by 137
González‐Sarrías, A., Romo‐Vaquero, M., García‐Villalba, R., Cortés‐Martín, A., Selma, M. V., & Espín, J. C. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800160 · Cited by 137
Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease
Basson, A., Trotter, A., Rodriguez-Palacios, A., & Cominelli, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00290 · Cited by 135
“Proteobacteria, particularly the presence of Escherichia coli (mainly AIEC) is higher in IBD (65–67), compared with healthy controls (59, 68).”
BackgroundRole of the gut microbiome in three major psychiatric disorders
Borkent, J., Ioannou, M., Laman, J. D., Haarman, B. C. M., & Sommer, I. E. (2022) · Psychological Medicine · doi:10.1017/s0033291722000897 · Cited by 152
“However, other studies have observed increased Lactobacillus as well in other disorders, like inflammatory bowel disease, indicating specific strains may have inflammatory potential (Wang et al., 2014).”
ResultInfluence of Microbiota on Intestinal Immune System in Ulcerative Colitis and Its Intervention
Zhang, S.-L., Wang, S., & Miao, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01674 · Cited by 151
Metabolomic analysis in inflammatory bowel disease: A systematic review
Gallagher, K., Catesson, A., Griffin, J. L., Holmes, E., & Williams, H. R. T. (2021) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjaa227 · Cited by 133
Wang, Z.-K. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14805 · Cited by 133
Intestinal Bacteria Composition and Translocation of Bacteria in Inflammatory Bowel Disease
Vrakas, S., Mountzouris, K. C., Michalopoulos, G., Karamanolis, G., Papatheodoridis, G., Tzathas, C., & Gazouli, M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170034 · Cited by 130
Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases
Grigg, J. B., & Sonnenberg, G. F. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601621 · Cited by 130
Probiotics, Nutrition, and the Small Intestine
Judkins, T. C., Archer, D. L., Kramer, D. C., & Solch-Ottaiano, R. J. (2020) · Current Gastroenterology Reports · doi:10.1007/s11894-019-0740-3 · Cited by 147
Suskind, D. L., Lee, D. Y., Kim, Y., Wahbeh, G. T., Singh, N., Braly, K., Nuding, M. E., Nicora, C., Purvine, S. O., Lipton, M. S. W., et al. (2020) · Nutrients · doi:10.3390/nu12123749 · Cited by 141
“prausnitzii abundance differs between different IBD types; being particularly depleted in ICD and less so in CD or UC [44,49,54,55].”
BackgroundAltered Gut Microbiota Related to Inflammatory Responses in Patients With Huntington’s Disease
Du, G., Dong, W., Yang, Q., Yu, X., Ma, J., Gu, W., & Huang, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.603594 · Cited by 122
“Family level analysis in our present study revealed significant increases in the abundance of Desulfovibrionaceae in the fecal samples of HD patients compared to those from healthy controls, whereas a previous study found that the abundance of Desulfovibrionaceae was increased in the feces of IBD patients (49), which…”
ResultInfluentialDysbiosis in the Gut Microbiota in Patients with Inflammatory Bowel Disease during Remission
Pisani, A., Rausch, P., Bang, C., Ellul, S., Tabone, T., Cordina, C. M., Zahra, G., Franke, A., & Ellul, P. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.00616-22 · Cited by 151
Wu, R., Xiong, R., Li, Y., Chen, J., & Yan, R. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103062 · Cited by 126
Selma-Royo, M., Calatayud Arroyo, M., García-Mantrana, I., Parra-Llorca, A., Escuriet, R., Martínez-Costa, C., & Collado, M. C. (2020) · Microbiome · doi:10.1186/s40168-020-00940-8 · Cited by 118
“The depletion of the Bifidobacterium species in the gut environment has been associated to immune-related diseases [41, 42], and members of this genus are commonly used as probiotics due to their capacity to modulate microbiota–immune system homeostasis [43].”
BackgroundShort chain fatty acids, a possible treatment option for autoimmune diseases
Golpour, F., Abbasi-Alaei, M., Babaei, F., Mirzababaei, M., Parvardeh, S., Mohammadi, G., & Nassiri‐Asl, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114763 · Cited by 133
Relationship between gut microbiota and development of T cell associated disease
Kosiewicz, M. M., Dryden, G. W., Chhabra, A., & Alard, P. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.03.019 · Cited by 117
“prausnitzii was decreased in both feces and biopsies of UC and CD patients [90].”
BackgroundGut Vibes in Parkinson's Disease: The Microbiota‐Gut‐Brain Axis
Bullich, C., Keshavarzian, A., Garssen, J., Kraneveld, A., & Perez‐Pardo, P. (2019) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12840 · Cited by 114
“Similarly, Wang and colleagues found enriched levels of Bifidobacterium and Lactobacillus accompanied by a reduction of pBP bacteria in fecal samples of patients with inflammatory bowel disease (IBD).(84) Gargari and colleagues recently showed that intake of Bifidobacterium bifidum decreases butyrate concentrations in…”
BackgroundKim, C. Y., Lee, M., Yang, S., Kim, K., Yong, D., Kim, H. R., & Lee, I. (2021) · Genome Medicine · doi:10.1186/s13073-021-00950-7 · Cited by 115
Intestinal microbiota and ulcerative colitis
Ohkusa, T., & Koido, S. (2015) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2015.07.010 · Cited by 132
Baldassano, S. N., & Bassett, D. S. (2016) · Scientific Reports · doi:10.1038/srep26087 · Cited by 112
Spalinger, M. R., Kasper, S. F., Chassard, C., Raselli, T., Frey-Wagner, I. M., Gottier, C., Lang, S., Atrott, K., Vavricka, S., Mair, F., et al. (2014) · Mucosal Immunology · doi:10.1038/mi.2014.122 · Cited by 111
Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences
Salem, F., Kindt, N., Marchesi, J. R., Netter, P., Lopez, A., Kokten, T., Danese, S., Jouzeau, J.-Y., Peyrin-Biroulet, L., & Moulin, D. (2019) · United European Gastroenterology Journal · doi:10.1177/2050640619867555 · Cited by 103
The emerging role of the gut microbiota and its application in inflammatory bowel disease
Xiu, W., Peng, J., Cai, P., Xia, Y., Yi, C., Shang, A., Akanyibah, F. A., & Mao, F. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117302 · Cited by 121
Altered gut microbiome composition in patients with Vogt-Koyanagi-Harada disease
Ye, Z., Wu, C., Zhang, N., Du, L., Cao, Q., Huang, X., Tang, J., Wang, Q., Li, F., Zhou, C., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1700754 · Cited by 109
“Butyrate also promotes gut health and has a role in controlling the permeability of the IEC.47 In the present study, the abundance of BPB Clostridium spp. was significantly decreased in active VKH patients, which is in line with earlier observations in other autoimmune or autoinflammatory diseases such as BD8 and IBD.…”
ResultFoditsch, C., Pereira, R. V. V., Ganda, E. K., Gomez, M. S., Marques, E. C., Santin, T., & Bicalho, R. C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145485 · Cited by 103
Zheng, H., Chen, M., Li, Y., Wang, Y., Lin, W., Liao, Z., Wang, M., Ma, F., Liao, Q., & Xie, Z. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01703 · Cited by 111
“But intriguing, previous study indicated that an increase of Bifidobacterium and Lactobacillus species was observed in patients with active CD (Wang et al., 2014).”
ResultAlegre, G. F. S., & Pastore, G. M. (2023) · Current Nutrition Reports · doi:10.1007/s13668-023-00475-y · Cited by 101
Secondary Bile Acids and Tumorigenesis in Colorectal Cancer
Liu, Y., Zhang, S., Zhou, W., Hu, D., Xu, H., & Ji, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.813745 · Cited by 118
“These bacteria can form a biological barrier in the intestinal tract through the placeholding effect, nutrition competition, and several secreted metabolites (65), which can reduce low-level inflammation in the body and protect the integrity of the intestinal wall.”
BackgroundLuceri, C., Femia, A. P., Fazi, M., Martino, C. D., Zolfanelli, F., Dolara, P., & Tonelli, F. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.09.005 · Cited by 105
Gobert, A. P., Sagrestani, G., Delmas, E., Wilson, K. T., Verriere, T. G., Dapoigny, M., Del’homme, C., & Bernalier-Donadille, A. (2016) · Scientific Reports · doi:10.1038/srep39399 · Cited by 98
Cao, X., Liu, K., Liu, J., Liu, Y.-W., Li, X., Wang, H., Zhu, Y., Wang, P., Li, Z., Wen, J., et al. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.635925 · Cited by 119
Levi, I., Gurevich, M., Perlman, G., Magalashvili, D., Menascu, S., Bar, N., Godneva, A., Zahavi, L., Chermon, D., Kosower, N., et al. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100246 · Cited by 111
Patrone, V., Puglisi, E., Cardinali, M., Schnitzler, T. S., Svegliati, S., Festa, A., Gabrielli, A., & Morelli, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-14889-6 · Cited by 101
Knoll, R. L., Forslund, S. K., Kultima, J. R., Meyer, C. U., Kullmer, U., Sunagawa, S., Bork, P., & Gehring, S. (2016) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00293.2016 · Cited by 103
Vladimirovna, G. M., Solodskikh, S. A., Panevina, A. V., Syromyatnikov, M., Dvoretskaya, Y. D., Свиридова, Т. Н., Попов, Е. С., & Popov, V. N. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06432 · Cited by 107
Isolation and Characterization of Faecalibacterium prausnitzii from Calves and Piglets
Foditsch, C., Santos, T. M. A., Teixeira, A. G. V., Pereira, R. V. V., Dias, J. M., Gaeta, N., & Bicalho, R. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0116465 · Cited by 94
Metadata
- Authors
- Wang, W., Chen, L., Zhou, R., Wang, X., Song, L., Huang, S., Wang, G., & Xia, B.
- Affiliations
- Zhongnan Hospital of Wuhan University (CN)
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2014-02
- Volume
- 52
- Issue
- 2
- Pages
- 398-406
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC3911339
- OpenAlex
- W2097788076
- Cited by
- 509
- References
- 48
- Citations by year
- 2026: 26 · 2025: 46 · 2024: 47 · 2023: 56 · 2022: 74 · 2021: 56 · 2020: 53 · 2019: 39 · 2018: 29 · 2017: 24 · 2016: 28 · 2015: 12 · 2014: 19
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- inflammatory bowel disease, Crohn's disease, ulcerative colitis, gut dysbiosis, Bifidobacterium, Lactobacillus, Faecalibacterium prausnitzii, butyrate-producing bacteria, mucosa-associated bacteria, fecal bacteria, probiotics, 16S rRNA gene
- MeSH terms
- Adolescent, Adult, Bifidobacterium, Biopsy, Butyrates, Feces, Female, Humans, Intestinal Mucosa, Lactobacillus, Male, Middle Aged, RNA, Bacterial, RNA, Ribosomal, 16S, Inflammatory Bowel Diseases, Gastrointestinal Tract, Young Adult, Biota, Bacterial Load, Real-Time Polymerase Chain Reaction, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.